Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.

The source of iron chelated in vivo by the new iron-chelating agent PIH and its mechanism of excretion have been studied in normal and hypertransfused rats. PIH is able to chelate iron from both parenchymal and RE iron stores. Unlike DF, which promotes both urinary and fecal iron excretion, in this model PIH-induced iron excretion is limited almost entirely to the gut. Response to PIH is directly related to dosage, and oral doses ranging from 125 to 500 mg/kg/day are well tolerated. Six additional imino derivatives of pyridoxal have been studied, but none of these new compounds was as effective as PIH. Our study indicates that oral PIH is comparable in efficiency with parenteral DF and is of potential usefulness in the management of iron overload.

[1]  P. Ponka,et al.  Biliary Iron Excretion in Rats following Pyridoxal Isonicotinoyl Hydrazone , 1980, British journal of haematology.

[2]  A. Williams,et al.  Effective Iron Chelation following Oral Administration of an Isoniazid‐Pyridoxal Hydrazone , 1979, British journal of haematology.

[3]  P. Ponka,et al.  Mobilization of iron from reticulocytes , 1979, FEBS letters.

[4]  B. Modell.  Advances in the use of iron-chelating agents for the treatment of iron overload. , 1979, Progress in hematology.

[5]  A. Cerami,et al.  Mechanism of iron chelation in the hypertransfused rat: definition of two alternative pathways of iron mobilization. , 1978, The Journal of laboratory and clinical medicine.

[6]  C. Hershko.  Determinants of fecal and urinary iron excretion in desferrioxamine- treated rats , 1978 .

[7]  W. Anderson,et al.  Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload , 1977 .

[8]  C. Hershko.  Storage iron regulation. , 1977, Progress in hematology.

[9]  C. Hershko.  A study of the chelating agent diethylenetriaminepentaacetic acid using selective radioiron probes of reticuloendothelial and parenchymal iron stores. , 1975, The Journal of laboratory and clinical medicine.

[10]  A. Unger,et al.  Hepatocellular Uptake of Ferritin in the Rat , 1974, British journal of haematology.

[11]  J. Cook,et al.  Storage iron kinetics. 3. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cells. , 1973, The Journal of laboratory and clinical medicine.

[12]  D. B. Mccormick,et al.  Pyridoxal phosphokinases. II. Effects of inhibitors. , 1961, The Journal of biological chemistry.